Table 1 Clinical/pathological characteristics of OC patients at initial diagnosis
Characteristics | No. (%) |
|---|---|
All cases | 32 |
Age, years | Â |
   Median (range) | 60 (45–76) |
FIGO Stage | Â |
   II | 1 (3.1) |
   IIIB | 2 (6.2) |
   IIIC | 27 (84.4) |
   IV | 2 (6.2) |
Histotype | Â |
   Serous | 26 (81.2) |
   Endometrioid | 2 (6.2) |
   Mucinous | 1 (3.1) |
   Undifferentiated | 3 (9.4) |
Grade | Â |
   G1-2 | 9 (28.1) |
   G3 | 19 (59.4) |
   n.a. | 4 (12.5) |
Ascites | Â |
   No | 16 (50.0) |
   Yes | 12 (37.5) |
   n.a. | 4 (12.5) |
Ca125, IU/ml | Â |
   Median (range) | 1,121 (11-9,082) |
Peritoneal carcinomatosis | Â |
   No | 11 (34.4) |
   Yes | 21 (65.6) |
Lymph node status (CT/Surgery) | Â |
   Positive | 19 (59.4) |
   Negative | 13 (40.6) |
Aortic +/- pelvic lymph node node sampling | Â |
   Yes | 10 (31.2) |
   No | 22 (68.8) |
Residual tumor at 1 st surgery (cm) | Â |
   < 0.5 | 14 (43.7) |
   0.5 – 2 | 6 (18.7) |
   > 2 | 12 (37.5) |
First line Chemotherapy | Â |
   Platinum-based | 6 (18.7) |
   Platinum/taxane-based | 26 (81.3) |